The Effect of Adding Kami-guibi-tang to Acetylcholinesterase Inhibitor Treatment on the Cognitive Function of Mild Alzheimer's Disease Patients: Study Protocol of a Randomized, Placebo-Controlled, Double-Blind Pilot Trial

다국어 초록 (Multilingual Abstract)

Background: Alzheimer's disease (AD) is a chronic neurodegenerative disease that causes disorientation, mood swings, problems with language, and difficulty remembering recent events. Acetylcholinesterase inhibitors (AchEIs) and memantine have been used to slow the course of the disease, but they can neither modify its progression nor prevent disease onset. Previous studies have suggested that Kami-guibi-tang (KGT) could be beneficial for supporting cognitive function in AD patients, but few clinical trials have been published. This pilot study aimed to evaluate the effect of KGT in improving cognitive function in AD patients.
Methods: The study will be a randomized, placebo-controlled, double-blind, single-center trial conducted using subjects diagnosed with mild AD by neurologists. Study subjects will be randomly assigned to either a treatment or control group. The treatment group will receive KGT granules for 24 weeks, while the control group will receive placebo granules. AchEI administration will be maintained in both groups during the entirety of the study. Subjects will be assessed using the following exams: the Seoul Neuropsychologic Screening Battery (SNSB) for cognitive function; brain magnetic resonance imaging (MRI) for brain metabolite, neurotransmitter, and cerebral blood flow (CBF) measurements; the Korean version of Quality of Life-Alzheimer's Disease (KQol-AD) for quality of life; the Caregiver-Administered Neuropsychiatric Inventory (CGA-NPI) for neurobehavioral symptoms; blood tests for amyloid and tau proteins and general blood parameters; and electrocardiography (ECG) before and after taking the medication.
Discussion: Our findings will provide insight into the feasibility of large-scale trials to consolidate evidence for the efficacy of KGT for dementia treatment.
Registration ID in CRIS: KCT0002904 (Clinical Research Information Service of the Republic of Korea).

참고문헌 (Reference)

1 신희영, "지역사회 거주 치매환자에서 한국판 삶의 질-알쯔하이머병 척도 개발을 위한 예비연구" 대한예방의학회 39 (39): 243-248, 2006

2 김학재, "스트레스와 에탄올로 유발된 mouse의 위점막 손상에 대한 귀비탕의 예방효과" 대한한의학회 24 (24): 155-168, 2003

3 은재순, "귀비탕이 Stress 부하 후 혈중 호르몬 및 비특이적 면역반응에 미치는 영향" 한의병리학회 18 (18): 172-178, 2004

4 馬 込敦, "認知症に対する加味帰脾湯の効果" 23 (23): 135-140, 2014

5 정연철, "歸脾湯이 자성 생쥐의 생식능력과 Caspase-3, MAPK , MPG 유전자 발현에 미치는 영향" 대한한방부인과학회 20 (20): 13-34, 2007

6 전희준, "歸脾湯이 Glutamate에 의한 성상세포의 손상에 미치는 영향" 대한한의학회 25 (25): 184-193, 2004

7 조인수, "歸脾湯 및 歸脾湯加紫河車 추출물 투여로 인한 卵巢摘出 흰쥐의 체중 및 지질대사 변화" 대한본초학회 19 (19): 85-90, 2004

8 Folstein MF, "“Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician" 12 (12): 189-198, 1975

9 Thorgrimsen L, "Whose quality of life is it anyway?The validity and reliability of the Quality of Life-Alzheimer's Disease (QoL-AD) scale" 17 (17): 201-208, 2003

10 Wimo A, "The worldwide economic impact of dementia 2010" 9 (9): 1-11, 2013

11 Oh MS, "The multi-herbal formula Guibi-tang enhances memory and increases cell proliferation in the rat hippocampus" 379 (379): 205-208, 2005

12 Lipczyńska-Łojkowska W, "The effect of rivastigmine on cognitive functions and regional cerebral blood flow in Alzheimer's disease and vascular dementia:follow-up for 2 years" 38 (38): 471-481, 2004

13 Kim SH, "The Radioprotective Effect of Kuei-Pi-Tang as a prescription of Traditional Chinese Medicine in Mice" 28 (28): 698-704, 1999

14 Nogami-Hara A, "The Japanese Angelica acutiloba root and yokukansan increase hippocampal acetylcholine level, prevent apoptosis and improve memory in a rat model of repeated cerebral ischemia" 214 : 190-196, 2018

15 Martin L, "Tau protein kinases:involvement in Alzheimer's disease" 12 (12): 289-309, 2013

16 Hilal S, "Subcortical Atrophy in Cognitive Impairment and Dementia" 48 (48): 813-823, 2015

17 Kang Y, "Seoul Neuropsychological Screening Battery (SNSB-II)" Human Brain Research & Consulting Co 2012

18 Griffith HR, "Proton magnetic resonance spectroscopy in dementias and mild cognitive impairment" 84 : 105-131, 2009

19 Qian YH, "Protective effect of ginsenoside Rb1 on beta-amyloid protein(1-42)-induced neurotoxicity in cortical neurons" 31 (31): 663-667, 2009

20 Reisberg B, "Overview of methodologic issues for pharmacologic trials in mild, moderate, and severe Alzheimer's disease" 8 (8): 159-193, 1996

21 Karttunen K, "Neuropsychiatric symptoms and quality of life in patients with very mild and mild Alzheimer's disease" 26 (26): 473-482, 2011

22 Egashira N, "Kamikihi-to, a Kampo medicine, ameliorates impairment of spatial memory in rats" 21 (21): 126-129, 2007

23 Tohda C, "Kamikihi-to (KKT) rescues axonal and synaptic degeneration associated with memory impairment in a mouse model of Alzheimer's disease, 5XFAD" 121 (121): 641-648, 2011

24 Meneghini V, "High-mobility group box-1 protein and β-amyloid oligomers promote neuronal differentiation of adult hippocampal neural progenitors via receptor for advanced glycation end products/nuclear factor-κB axis:relevance for Alzheimer's disease" 33 (33): 6047-6059, 2013

25 Corder EH, "Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families" 261 (261): 921-923, 1993

26 Porges EC, "Frontal Gamma- Aminobutyric Acid Concentrations Are Associated With Cognitive Performance in Older Adults" 2 (2): 38-44, 2017

27 Zhang H, "Effects of tenuifolin extracted from radix polygalae on learning and memory:a behavioral and biochemical study on aged and amnesic mice" 15 (15): 587-594, 2008

28 Ishida K, "Effect of donepezil and kamikihito combination therapy on cognitive function in A lzheimer's disease:R etrospective study" 3 (3): 94-99, 2016

29 이주원, "Effect of Guibi-tang on Neuronal Apoptosis and Cognitive Impairment Induced by Beta Amyloid in Mice" 대한한의학회 35 (35): 10-23, 2014

30 김정훈, "EBM 기반구축을 위한 歸脾湯 연구 문헌 분석" 대한한방신경정신과학회 20 (20): 205-216, 2009

31 조민지, "Comparison of the effect of three licorice varieties on cognitive improvement via an amelioration of neuroinflammation in lipopolysaccharide-induced mice" 한국영양학회 12 (12): 191-198, 2018

32 O'Brien JT, "Clinical practice with anti-dementia drugs:A revised (third) consensus statement from the British Association for Psychopharmacology" 31 (31): 147-168, 2017

33 Beason-Held LL, "Changes in brain function occur years before the onset of cognitive impairment" 33 (33): 18008-18014, 2013

34 Kang SJ, "Caregiver-Administered Neuropsychiatric Inventory (CGA-NPI)" 17 (17): 32-35, 2004

35 Kok E, "Apolipoprotein E-dependent accumulation of Alzheimer disease- related lesions begins in middle age" 65 (65): 650-657, 2009

36 Harper L, "An algorithmic approach to structural imaging in dementia" 85 (85): 692-698, 2014

37 Citron M, "Alzheimer's disease:strategies for disease modification" 9 (9): 387-398, 2010

38 Walsh DM, "Alzheimer's disease and the amyloid β-protein" 107 : 101-124, 2012

39 Burns A, "Alzheimer's disease" 338 : b158-, 2009

40 Chao LL, "ASL perfusion MRI predicts cognitive decline and conversion from MCI to dementia" 24 (24): 19-27, 2010

41 "A validity study on the korean mini-mental state examination (K-MMSE) in dementia patients" 15 (15): 300-308, 1997

42 Park IK, "A Study on the Homostatic Effects of Guipitang and Guipitangjiaweifang Extracts in Experimental Animals" 16 (16): 63-76, 2003